Publications by authors named "Yu-Shan Fu"

Letter to the Editor-in-Chief in response to article "Early Surgery Versus Exercise Therapy and Patient Education for Traumatic and Nontraumatic Meniscal Tears in Young Adults-an Exploratory Analysis From the DREAM Trial" by Damsted et al. .

View Article and Find Full Text PDF

Long-term Glucocorticoid (GC) use results in compromised bone strength and fractures, and several treatment recommendations have been developed to prevent fractures, but none have been validated in a real-world setting. This study aims to create a treatment decision tool and compares this tool to the treatment suggestions from the American College of Rheumatology (ACR), International Osteoporosis Foundation and European Calcified Tissue Society (IOF-ECTS), and GC-adjusted Fracture Risk Assessment Tool (GC-FRAX), above the intervention threshold. We utilized registry data gathered at Chang Gung Memorial Hospital at Kaohsiung, Taiwan, between September 2014 and April 2021.

View Article and Find Full Text PDF

Background: Rheumatoid arthritis (RA) is a systemic inflammatory disease in which TNF-α plays an important role. Fibroblast growth factor receptor 3 (FGFR3) is reportedly involved in RA by regulating the expression of inflammatory cytokines.

Objective: This study examined the expression profile of FGFR3 in human synovial biopsy tissues and evaluated its gene-silencing effects on behaviors of synovial cells.

View Article and Find Full Text PDF
Article Synopsis
  • Patients with rheumatoid arthritis have an increased risk of developing diabetes, which can lead to serious health issues like cardiovascular diseases.
  • This study analyzed data from over 5,500 rheumatoid arthritis patients to see how different treatments (like DMARDs) affect the risk of diabetes onset.
  • Results indicated that using biological DMARDs, methotrexate combinations, and certain other conventional DMARDs significantly reduced the risk of diabetes compared to methotrexate monotherapy, with hydroxychloroquine being particularly effective.
View Article and Find Full Text PDF

Background: To evaluate the factors to predict subclinical inflammation of wrist joints in patients with RA who are in clinical remission or low disease activity.

Methods: Gray scale and power Doppler ultrasound were performed on the dorsal radio-lunate of both wrists. The presence of synovitis, comorbidities, and use of disease modifying anti-rheumatic drugs were recorded.

View Article and Find Full Text PDF

The implementation of competency-based medical education (CBME) focuses on learners' competency outcomes and performance during their training. Competencies should meet the local demands of the healthcare system and achieve the desired patient-centered outcomes. Continuous professional education for all physicians also emphasizes competency-based training to provide high-quality patient care.

View Article and Find Full Text PDF

Background: Osteoporosis increases the risk of fractures. Visceral fat is associated with cardiovascular disease (CVD). There is inadequate knowledge on the relationship between osteoporosis and visceral fat.

View Article and Find Full Text PDF

Danazol is a treatment option for autoimmune hemolytic anemia (AIHA) and immune thrombocytopenia (ITP). Three patients with AIHA and eight patients with ITP between 2008 and 2022 were enrolled in the Rheumatology Outpatient Clinic of Chang Gung Memorial Hospital, Kaohsiung. Those patients were refractory or intolerant to conventional therapy and were treated with danazol.

View Article and Find Full Text PDF

Shared decision making (SDM) is an interactive process that involves patients and their healthcare professionals reaching joint decisions about medical care through negotiation. As the initiators of medical decision-making in daily routine, physicians should be aware of and concerned about the SDM process. Thus, professional competency development for SDM has become increasingly critical for physicians' training.

View Article and Find Full Text PDF

Shared decision making (SDM) is a collaborative process involving patients and their healthcare workers negotiating to reach a shared decision about medical care. However, various physician stakeholders (attending physicians, medical residents, and doctors in post-graduate years) may have different viewpoints on SDM processes. The purpose of this study is to explore the core competence of physicians in performing SDM tasks and to investigate the significant competency development aspects/criteria by applying the literature research and expert interviews.

View Article and Find Full Text PDF

Objective: To explore the impact of seropositivity on systemic bone loss in rheumatoid arthritis (RA).

Methods: We conducted an interim analysis of the RA registry. Patients were examined with dual-energy X-ray absorptiometry at baseline and again 3 years later.

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to create a FRAX®-based prediction model specifically for identifying fragility fractures in rheumatoid arthritis (RA) patients over a 3-year period.
  • - Data was collected from 493 RA patients, revealing that 23.5% experienced new fragility fractures, with the fixed intervention threshold (FITD) showing strong effectiveness compared to other models.
  • - The findings suggest that the FIT model can help healthcare providers make effective interventions to prevent fragility fractures in RA patients, offering a practical guideline for care.
View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the changes in bone mineral density (BMD) among rheumatoid arthritis (RA) patients treated with different medications over three years, specifically conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs), tumor necrosis factor-α inhibitors (TNFi), and abatacept.
  • A total of 752 RA patients were recruited, with 485 completing the study; results showed that BMD decreased significantly for those on csDMARDs and TNFi, while it remained stable in those receiving abatacept.
  • The findings suggest that abatacept may be more effective in preserving BMD compared to csDMARDs and TNFi, indicating the importance of anti-osteoporosis therapies in preventing bone
View Article and Find Full Text PDF
Article Synopsis
  • Researchers created the Male Osteoporosis Self-Assessment Tool for Taiwan (MOSTAi) to help identify Taiwanese men at risk for osteoporosis, as existing tools are seldom used for this demographic.
  • The tool is based on a questionnaire that assesses clinical risk factors, and its effectiveness was validated using a receiver operating characteristic (ROC) curve on data from 2,290 participants.
  • The final MOSTAi formula considers age and weight, with a cutoff score of 11 to determine risk, highlighting the need for region-specific assessment models for better osteoporosis detection.
View Article and Find Full Text PDF

In the intensive care unit (ICU), renal failure and respiratory failure are two of the most common organ failures in patients with systemic inflammatory response syndrome (SIRS). These clinical symptoms usually result from sepsis, trauma, hypermetabolism or shock. If this syndrome is caused by septic shock, the Surviving Sepsis Campaign Bundle suggests that vasopressin be given to maintain mean arterial pressure (MAP) > 65 mmHg if the patient is hypotensive after fluid resuscitation.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify risk factors for fragility fractures in rheumatoid arthritis (RA) patients over a 3-year period through an observational cohort study at Chang Gung Memorial Hospital.
  • A total of 477 RA patients were tracked, with 103 having new fractures (Group A) and 206 not having any fractures (Group B), analyzing factors like co-morbidities and fracture history.
  • Findings indicated that the most significant risk factor for new fragility fractures in RA patients was a previous fracture, highlighting its role alongside other demographics and disease-related factors.
View Article and Find Full Text PDF
Article Synopsis
  • Rheumatoid arthritis (RA) is linked to decreased bone mineral density (BMD), and this study aimed to investigate how high disease activity affects long-term bone loss.
  • The research involved 477 RA patients categorized based on their disease activity levels and included BMD assessments at the start and after three years.
  • The findings indicated that patients in remission who used anti-osteoporosis treatment saw improved BMD, while those with moderate or high disease activity experienced significant bone loss, highlighting the importance of managing disease activity.
View Article and Find Full Text PDF

Background: Hormonal changes had been found in menopausal women. Muscle and bone mass decline after menopause and with aging, increasing the risk for sarcopenia and osteoporosis in later life. Only a few studies suggest that menopausal hormonal changes have an effect on the decline in muscle mass.

View Article and Find Full Text PDF

Objectives: To investigate changes in BMD in RA patients receiving 3-year biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARD) or conventional synthetic DMARD (csDMARD).

Methods: Patients with RA were recruited from September 2014 until March 2019. Clinical characteristics, BMD and evidence of fragility fractures at enrolment were documented.

View Article and Find Full Text PDF

Background: We investigated the association of anti-osteoporosis medication with mortality risk in older adults with hip fractures and evaluated the influence of medication adherence on mortality.

Methods: We conducted a population-based cohort study and identified a total of 13,123 patients aged 65 years or older with hip fracture from the Taiwan National Health Insurance Database during the period 2001-2010. Individuals with (n = 2092) and without (n = 2092) receiving anti-osteoporosis medication were matched using propensity score matching (1:1 ratio).

View Article and Find Full Text PDF

Unlabelled: Fracture Risk Assessment Tool (FRAX)-based intervention threshold (IT) is widely applied for treatment decision-making; however, an IT based on FRAX without the measurement of bone mass density (BMD) has not been validated. The study demonstrated that estimates of fracture risk by FRAX without BMD were higher than those by FRAX with BMD in women with old age.

Introduction: BMD is an integral component for bone strength assessment, but age-specific impacts of BMD on fracture risk assessment and therapeutic decision-making remained unclear.

View Article and Find Full Text PDF

Introduction: The aim of this study was to develop an algorithm to identify high-risk populations of fragility fractures in Taiwan.

Materials And Methods: A total of 16,539 postmenopausal women and men (age ≥ 50 years) were identified from the Taiwan Osteoporosis Survey database. Using the Taiwan FRAX tool, the 10-year probability of major osteoporotic fracture (MOF) and hip fracture (HF) and the individual intervention threshold (IIT) of each participant were calculated.

View Article and Find Full Text PDF